Autor: |
Spratt DE; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Cleveland, Ohio. Electronic address: Daniel.Spratt@uhhospitals.org., Liu VYT; Veracyte, Inc, South San Francisco, California., Michalski J; Department of Radiation Oncology, Washington University, St. Louis, Missouri., Davicioni E; Veracyte, Inc, South San Francisco, California., Berlin A; Princess Margaret Cancer Centre, Cancer Clinical Research Unit, Toronto, Ontario, Canada., Simko JP; Department of Pathology, UCSF Medical Center-Mount Zion, San Francisco, California., Efstathiou JA; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Tran PT; Department of Pathology, University of Maryland, Baltimore, Maryland., Sandler HM; Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California., Hall WA; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin., Thompson DJS; Veracyte, Inc, South San Francisco, California., Parliament MB; Division of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada., Dayes IS; Division of Radiation Oncology, Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada., Correa RJM; Department of Oncology, London Regional Cancer Program, London, Ontario, Canada., Robertson JM; Department of Radiation Oncology, Beaumont Health CCOP, Royal Oak, Michigan., Gore EM; Department of Radiation Oncology, Milwaukee VA Medical Center, Milwaukee, Wisconsin., Doncals DE; Division of Radiation Oncology, Akron City Hospital, Akron, Ohio., Vigneault E; Department of Radiation Oncology, CHU de Quebec Universite Laval, Quebec, Quebec, Canada., Souhami L; Department of Radiation Oncology, Cedars Cancer Centre, McGill University, Montreal, Quebec, Canada., Karrison TG; NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania., Feng FY; Department of Radiation Oncology, University of California San Francisco, San Francisco, California. |